Cancer Distribution Among Asian, Native Hawaiian, and Pacific Islander Subgroups — United States, 2015–2019

Non-Hispanic Asian (Asian) and non-Hispanic Native Hawaiian and Pacific Islander (NHPI) persons represent growing segments of the U.S. population (1). Epidemiologic cancer studies often aggregate Asian and NHPI persons (2,3); however, because Asian and NHPI persons are culturally, geographically, and linguistically diverse (2,4), subgroup analyses might provide insights into the distribution of health outcomes. To examine the frequency and percentage of new cancer cases among 25 Asian and NHPI subgroups, CDC analyzed the most current 2015–2019 U.S. Cancer Statistics data.* The distribution of new cancer cases among Asian and NHPI subgroups differed by sex, age, cancer type, and stage at diagnosis (for screening-detected cancers). The percentage of cases diagnosed among females ranged from 47.1% to 68.2% and among persons aged <40 years, ranged from 3.1% to 20.2%. Among the 25 subgroups, the most common cancer type varied. For example, although breast cancer was the most common in 18 subgroups, lung cancer was the most common cancer among Chamoru, Micronesian race not otherwise specified (NOS), and Vietnamese persons; colorectal cancer was the most common cancer among Cambodian, Hmong, Laotian, and Papua New Guinean persons. The frequency of late-stage cancer diagnoses among all subgroups ranged from 25.7% to 40.3% (breast), 38.1% to 61.1% (cervical), 52.4% to 64.7% (colorectal), and 70.0% to 78.5% (lung). Subgroup data illustrate health disparities among Asian and NHPI persons, which might be reduced through the design and implementation of culturally and linguistically responsive cancer prevention and control programs, including programs that address social determinants of health.

Invasive cancer cases were defined according to the World Health Organization International Classification of Diseases for Oncology, Third Edition^† diagnosed during 2015–2019 using the most current U.S. Cancer Statistics data. This source of high-quality incidence data from population-based cancer registries, supported by CDC’s National Program of Cancer Registries and the National Cancer Institute’s Surveillance, Epidemiology, and End Results Program, covers approximately 99% of the U.S. population during the 5-year period.

Central cancer registries collect race and ethnicity information from different sources, including self-reported intake questionnaires, abstracted patient records, electronic health records, linkages to administrative databases, and algorithms to impute missing data (5). The current analysis is restricted to Asian and NHPI persons who reported non-Hispanic ethnicity. Race was recorded by standardized coding methods using 30 race groups, including 25 Asian and NHPI subgroups.^§ Some subgroups were defined by region rather than race (e.g., Micronesian race NOS). Because of low case counts, in some analyses, Cambodian, Hmong, Laotian, and Thai persons were aggregated into an Other Southeast Asian group.^¶ Data for other racial groups are available in the Data Visualizations Tool** (Supplementary Table, https://stacks.cdc.gov/view/cdc/126010). Cases were stratified by race, sex, and age for all cancers combined and then categorized into the 10 most common cancer types among all Asian and NHPI persons. A subset of cancer types detectable by screening^†† (i.e., female breast, colon and rectum, lung and bronchus, and cervix uteri) were further categorized by stage at diagnosis as early-stage, late-stage, or unknown.^§§ Because current national population denominators are not available for all subgroups, results are presented as frequencies and percentages rather than rates. In all analyses, cells containing fewer than six cases were suppressed to protect confidentiality and reduce misinterpretation or misuse of unstable counts. This activity was reviewed by CDC and was conducted consistent with applicable federal law and CDC policy.^¶¶

During 2015–2019, a total of 273,656 new invasive cancer cases were reported among Asian persons and 18,491 among NHPI persons in the United States (Table 1); these included 92,562 in East Asian persons (31.7% of all cases among Asian and NHPI persons), 71,721 in Southeast Asian persons (24.5%), 44,890 in South Asian persons (15.4%), and 64,483 in Other Asian persons (22.1%). Approximately one half of cases among Asian (56.2%) and NHPI (56.5%) persons were diagnosed in females, and approximately one tenth were diagnosed in persons aged <40 years (including 8.5% in Asian and 9.6% in NHPI persons). Across subgroups, the highest percentages of new cancer cases among females occurred among Tahitian (68.2%), Thai (65.5%), and Fiji Islander (65.1%) subgroups. The percentage of new cancer cases in persons aged <40 years was highest among Hmong (20.2%), Micronesian race NOS (18.1%), and Melanesian race NOS persons (15.7%), and lowest among Japanese persons (3.1%).

Breast cancer accounted for the highest proportion of new cancer diagnoses among 18 (72.0%) of the 25 Asian and NHPI subgroups. Lung cancer was the most common cancer among Chamoru, Micronesian race NOS, and Vietnamese persons; colorectal cancer was the most common cancer among Cambodian, Hmong, Laotian, and Papua New Guinean persons (Table 2) (Supplementary Table, https://stacks.cdc.gov/view/cdc/126010).

Among Asian and NHPI subgroups, the frequency of late-stage diagnoses for screening-detected cancers ranged from 25.7% (Japanese) to 40.2% (Other Southeast Asian) and 40.3% (Pacific Islander) for breast cancer; from 38.1% (Other Asian) to 61.1% (Korean) for cervical cancer; from 52.4% (Other Asian) to 64.7% (Other Southeast Asian) for colorectal cancer; and from 70.0% (Other Asian) to 78.5% (Other Southeast Asian) for lung cancer (Table 3).

Acknowledgments

Central cancer registry personnel; Ana Penman-Aguilar.

Corresponding author: Suzanne Bock, [email protected].

¹Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, CDC.

References

1. Vespa J, Medina L, Armstrong DW. Demographic turning points for the United States: population projections for 2020 to 2060. Washington, DC: US Department of Commerce, US Census Bureau; 2020. https://www.census.gov/library/publications/2020/demo/p25-1144.html
2. American Cancer Society. Special section: cancer in Asian Americans, Native Hawaiians, and Pacific Islanders. Atlanta, GA: American Cancer Society; 2016. https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2016/special-section-cancer-in-asian-americans-native-hawaiians-and-pacific-islanders-cancer-facts-and-figures-2016.pdf
3. Liu L, Zhang J, Deapen D, et al. Differences in pancreatic cancer incidence rates and temporal trends across Asian subpopulations in California (1988–2015). Pancreas 2019;48:931–3. https://doi.org/10.1097/MPA.0000000000001337 PMID:31180980
4. Office of Minority Health. Profile: Asian Americans. Rockville, MD: US Department of Health and Human Services; 2021. https://www.minorityhealth.hhs.gov/omh/browse.aspx?lvl=3&lvlid=63
5. CDC. United States cancer statistics: interpreting race and ethnicity in cancer data. Atlanta, GA: US Department of Health and Human Services, CDC; 2022. https://www.cdc.gov/cancer/uscs/technical_notes/interpreting/race.htm
6. Miller BA, Chu KC, Hankey BF, Ries LAG. Cancer incidence and mortality patterns among specific Asian and Pacific Islander populations in the U.S. Cancer Causes Control 2008;19:227–56. https://doi.org/10.1007/s10552-007-9088-3 PMID:18066673
7. Sabatino SA, Thompson TD, White MC, et al. Cancer screening test receipt—United States, 2018. MMWR Morb Mortal Wkly Rep 2021;70:29–35. https://doi.org/10.15585/mmwr.mm7002a1 PMID:33444294
8. DeGroff A, Miller J, Sharma K, et al. COVID-19 impact on screening test volume through the National Breast and Cervical Cancer early detection program, January–June 2020, in the United States. Prev Med 2021;151:106559. https://doi.org/10.1016/j.ypmed.2021.106559 PMID:34217410
9. Flores YN, Datta GD, Yang L, et al. Disparities in hepatocellular carcinoma incidence, stage, and survival: a large population-based study. Cancer Epidemiol Biomarkers Prev 2021;30:1193–9. https://doi.org/10.1158/1055-9965.EPI-20-1088 PMID:33737301
10. Hacker K, Auerbach J, Ikeda R, Philip C, Houry D; SDOH Task Force. Social determinants of health—an approach taken at CDC. J Public Health Manag Pract 2022;28:589–94. https://doi.org/10.1097/PHH.0000000000001626 PMID:36194813

Abbreviation: NOS = not otherwise specified.
* Cancer incidence data were compiled from registries that meet the data quality criteria for all invasive cancer sites combined, representing 99% of the U.S. population.
^† The current analysis is restricted to persons who reported non-Hispanic ethnicity.
^§ The denominator used to calculate percentages of new cancer cases among Asian American, Native Hawaiian, and Pacific Islander population is 292,147.
^¶ Percentage calculated using each racial group’s total number of cases as a denominator.
** Counts from suppressed cells are included in the aggregate totals.
^†† Dashes indicate that counts were suppressed because fewer than six cases were reported or for complementary cell suppression.

Abbreviation: NOS = not otherwise specified.
* Percentage was calculated by dividing the number of new cancer cases for 10 common cancer types by the total number of cancer cases in each racial group. The cancer types are based on the 10 most common cancer types diagnosed among all Asian American, Native Hawaiian, and Pacific Islander persons combined.
^† Cancer incidence data were compiled from registries that meet the data quality criteria for all invasive cancer sites combined, representing 99% of the U.S. population.
^§ The current analysis is restricted to persons who reported non-Hispanic ethnicity.
^¶ Dashes indicate that counts were suppressed because fewer than six cases were reported.

Abbreviation: NOS = not otherwise specified.
* Early-stage (localized) cancer is confined to the primary site, and late-stage (regional or distant stage) cancer has spread to lymph nodes or other parts of the body. Cases identified only through autopsies or death certificates were excluded from the stage analyses.
^† Cancer incidence data were compiled from cancer registries that meet the data quality criteria for all invasive cancer sites combined, representing 99% of the U.S. population.
^§ The current analysis is restricted to persons who reported non-Hispanic ethnicity.
^¶ Groups were combined as follows: Other Southeast Asian includes Cambodian, Hmong, Laotian, and Thai persons; South Asian includes Asian Indian, Pakistani, and Asian Indian or Pakistani race NOS persons; Pacific Islander includes Chamoru, Fiji Islander, Guamanian race NOS, Melanesian race NOS, Micronesian race NOS, Papua New Guinean, Polynesian race NOS, Samoan, Tahitian, Tongan, and Pacific Islander race NOS persons; Other Asian includes data for persons whose race was not further specified or who are members of racial groups that did not include the other 24 Asian American, Native Hawaiian, or other Pacific Islander subgroups.
** Counts were suppressed because fewer than six cases were reported.